Hair Loss
Conditions
Interventions
Group 1:Using LT010 Tincture-001
Group 2:Using LT010 Tincture-002
Group 3:Using LT010 Tincture-003
Group 4:Using LT010 Tincture-004
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Healthy males or females aged 18-60 (males preferred, with at least 8 males enrolled in each group); (2) The clinical diagnosis is androgenic alopecia, with Hamilton Norwood grading of IIIa, III, IIIv, IV, IVa, V in males, and Savin grading of D3 to D6 in females; (3) Individuals who have not undergone any special hair styling treatments such as dyeing, perming, or shaping within the past month; (4) Willing to maintain the same hairstyle, color, and length during the research period, without using special hair care products or hair care; (5) Agree to follow the trial treatment plan and visit plan, voluntarily enroll, and sign an informed consent form in writing.
Exclusion criteria
Exclusion criteria: (1) Pregnant or lactating women, or those planning to conceive within 6 months; (2) Individuals with other types of hair loss, such as alopecia areata or diffuse alopecia areata, syphilis alopecia, scar alopecia, malnutrition, and hair loss caused by chemotherapy/radiation therapy; (3) Patients with scalp skin diseases that affect efficacy evaluation, those with scalp injuries or other scalp skin lesions that require topical medication treatment, such as fungal or bacterial infections, severe seborrheic dermatitis, scalp psoriasis, contact dermatitis, severe folliculitis or scalp atrophy, etc; (4) Individuals who have received hair transplant treatment before; (5) Those who have used cosmetics, health products, or other products with anti hair loss or hair growth effects within the past 6 months; (6) Individuals with systemic diseases such as cardiovascular, endocrine, or metabolic disorders, as well as those with immunodeficiency or autoimmune diseases; (7) Asthma or other chronic respiratory disease patients undergoing treatment, or those with infectious diseases; (8) Individuals with mental or psychological disorders; (9) Individuals with high physical sensitivity; (10) Individuals who have participated in previous studies or other clinical trials within 6 months; (11) Individuals who have received anti-cancer chemotherapy within the past 6 months; (12) Clinical evaluation deemed unsuitable for participants in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall hair density;Local hair density;Safety assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical evaluation;Quality of Life Questionnaire;Patient satisfaction score; | — |
Countries
China
Contacts
Public ContactLi Li
West China Hospital, Sichuan University
Outcome results
None listed